NCT05529966Completed

Comparing NGENUITY vs Conventional Microscope in a New Hydrus User

Source: ClinicalTrials.gov · Last updated 17 Apr 2025

Brief summary (registry, in English)

To compare the potential efficiency and educational value of using NGENUITY (3D camera system, FDA approved for this indication) vs the conventional microscope for Hydrus microstent placement by new users.

Status (registry): Completed
Study type: Interventional
Enrollment: 32 (actual)
First submitted: 2 Sept 2022
Start date: 13 Feb 2023
Primary completion date: 22 Mar 2024
Lead sponsor: Stanford University
Diseases: Glaucoma
NCT number: NCT05529966

What you commit to

Study type: Interventional
Participants enrolled: 32
From 13 Feb 2023 to the primary completion date, 22 Mar 2024
1 site in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

Unable to properly visualize the angle due to complicated cataract surgery

Other

Lack of patient cooperation severely affecting ability to place stent with any visualization technique
Angle abnormalities including PAS in nasal quadrant

Who the study is looking for

Patients with mild to moderate primary open angle glaucoma as defined by AGS with visually significant age-related cataract undergoing uncomplicated cataract surgery and Hydrus microstent
Either eye or both eyes may participate

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Site	City	Country	Site status
Byers Eye Institute Coordinator of this site? Confirm its status	Palo Alto	United States	Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.